Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2013
10/03/2013WO2013147216A1 (2-heteroarylamino)succinic acid derivative
10/03/2013WO2013147215A1 4-alkanoylamino-3-pyrazolone derivative
10/03/2013WO2013147214A1 5-hydroxypyrimidine-4-carboxamide derivative
10/03/2013WO2013147183A1 Triazinone compound and t-type calcium channel inhibitor
10/03/2013WO2013147161A1 Nipecotic acid derivative and use thereof for medical purposes
10/03/2013WO2013147160A1 Cyclic amine derivative and use thereof for medical purposes
10/03/2013WO2013147117A1 Fused azole derivative
10/03/2013WO2013147026A1 Aromatic ring compound
10/03/2013WO2013146970A1 Novel quinoline derivative
10/03/2013WO2013146969A1 Novel disubstituted cyclohexane derivative
10/03/2013WO2013146963A1 Heterocyclic compound
10/03/2013WO2013146645A1 Organic electroluminescent element
10/03/2013WO2013144971A1 New solid forms of dabigatran etexilate bisulfate and mesylate and processes to prepare them
10/03/2013WO2013144903A1 Processes for the preparation of dabigatran etexilate
10/03/2013WO2013144234A1 1,2,4 -triazole derivatives as herbicidals
10/03/2013WO2013144231A1 Herbicidal compounds
10/03/2013WO2013144224A1 Acetylenic microbiocides
10/03/2013WO2013144223A1 N-substituted pyrimidinylidene compounds and derivatives for combating animal pests
10/03/2013WO2013144213A1 N-substituted pyridinylidene compounds and derivatives for combating animal pests
10/03/2013WO2013144191A1 Substituted 2-amino-3-cyanopyridines as inhibitors of sodium-calcium exchange and use thereof for cardiovascular diseases
10/03/2013WO2013144187A1 5-aminopyrimidine derivatives and use thereof for combating undesired plant growth
10/03/2013WO2013144129A1 Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
10/03/2013WO2013143967A1 Polymorph of barnidipine hydrochloride and processes for its preparation
10/03/2013WO2013143597A1 Demethylase enzymes inhibitors
10/03/2013WO2013088452A3 Quinoline derivatives as renin inhibitors
10/03/2013US20130261307 Process for the manufacturing of crr inhibitors
10/03/2013US20130261299 Pyridazinyl derivatives as smo inhibitors
10/03/2013US20130261155 1-(heterocyclic carbonyl) piperidines
10/03/2013US20130261141 Novel heterocyclic compounds as pesticides
10/03/2013US20130261139 Use of a quinazoline compound in preparing a medicament against flaviviridae virus
10/03/2013US20130261135 Metalloenzyme inhibitor compounds
10/03/2013US20130261130 Neurotrypsin inhibitors
10/03/2013US20130261128 Continuous arycyclic compound
10/03/2013US20130261125 Indazole derivatives useful as erk inhibitors
10/03/2013US20130261123 Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
10/03/2013US20130261118 Compounds for alzheimer's disease
10/03/2013US20130261100 Pyridine amide derivatives as ep4 receptor antagonists
10/03/2013US20130261081 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine
10/03/2013US20130259830 Crth2 modulators
10/02/2013EP2644600A1 Heterocyclic aspartyl protease inhibitors
10/02/2013EP2643312A1 Microbicidal heterocycles
10/02/2013EP2643311A1 Bicyclic gpr119 modulators
10/02/2013EP2643310A1 4- (5-cyano-pyrazol-1-yl) -piperidine derivatives as gpr 119 modulators
10/02/2013EP2643302A1 Insecticidal compounds
10/02/2013EP2643299A1 Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions
10/02/2013EP2643298A1 Substituted cyclopentyl - azines as casr- active compounds
10/02/2013EP2295423B1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
10/02/2013CN103339132A Novel purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredi
10/02/2013CN103339124A Method for producing di(arylamino)aryl compound, and synthetic intermediate therefor
10/02/2013CN103339115A Metalloenzyme inhibitor compounds
10/02/2013CN103339111A Bicyclic acetyl-CoA carboxylase inhibitors
10/02/2013CN103339110A Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
10/02/2013CN103339109A Tetrahydroisoquinoline derivative
10/02/2013CN103339108A Protease activated receptor 2 (par2) antagonists
10/02/2013CN103333679A Excited state intramolecular proton transfer regulation based fluorescence probe, and synthetic method and applications thereof
10/02/2013CN103333678A One and two-photon mitochondrion fluorescence probe and application thereof
10/02/2013CN103333162A 病毒聚合酶抑制剂 Viral polymerase inhibitors
10/02/2013CN103333158A N-phenylcarbazole derivative and application thereof to electrophosphorescent device
10/02/2013CN103333157A Pyridine carboxamide derivative as kinase inhibitor
10/02/2013CN103333156A Preparation method of 2-substituted arylethenyl-N-methylated quinoline derivative and application of 2-substituted arylethenyl-N-methylated quinoline derivative in preparation of drug for treating Alzheimer disease
10/02/2013CN102458402B Nicotinamide compounds useful as kinase modulators
10/02/2013CN102186818B 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases
10/02/2013CN101679251B (Aza)indole derivative and use thereof for medical purposes
10/01/2013US8546581 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide
10/01/2013US8546569 Chemical compounds
10/01/2013US8546505 Carbazole-based hole transport and/or electron blocking materials and/or host polymer materials
10/01/2013US8546431 5-lipoxygenase-activating protein (FLAP) inhibitors
10/01/2013US8546430 Thalidomide analogs
10/01/2013US8546429 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/01/2013US8546415 Bis-pyridino containing compounds for the use in the treatment of CNS pathologies
10/01/2013US8546405 Anti-viral compounds
10/01/2013US8546404 Compounds that are ERK inhibitors
10/01/2013US8546403 Compounds that modulate intracellular calcium
10/01/2013US8546401 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases
10/01/2013US8546399 Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
10/01/2013US8546398 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
10/01/2013US8546396 N-(hetero)aryl, 2-(hetero)aryl—substituted acetamides for use as Wnt signaling modulators
10/01/2013US8546389 Viral polymerase inhibitors
10/01/2013US8546374 Amino-tetrazoles analogues and methods of use
10/01/2013US8546368 Pyrazoloquinolones are potent PARP inhibitors
10/01/2013CA2723545C 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2
10/01/2013CA2719876C Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/01/2013CA2710959C Imidazole carbonyl compounds and use thereof for treating bacterial infections
10/01/2013CA2619010C Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/01/2013CA2608099C Dipyridyl-dihydropyrazolones and their use
10/01/2013CA2594508C Cyanoguanidine compounds
10/01/2013CA2565568C Pyrimidines as plk inhibitors
10/01/2013CA2532152C Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/01/2013CA2531507C Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
09/2013
09/26/2013WO2013142346A1 Premature-termination-codons readthrough compounds
09/26/2013WO2013142307A1 Carbamate compounds and of making and using same
09/26/2013WO2013141586A1 Novelpyridopyrimidine derivatives and use thereof
09/26/2013WO2013141057A1 Organic electroluminescence element
09/26/2013WO2013141014A1 Novel compound and photosensitive resin composition
09/26/2013WO2013140148A1 Quinazoline compounds and their use in therapy
09/26/2013WO2013140120A1 Glycerol solvate forms of (r) - 2 - [ [ [3 -methyl -4 (2,2, 2 - trifluoroethoxy) pyridin- 2 - yl] methyl] sulphinyl] - 1h - ben zimidazole
09/26/2013WO2013139929A1 Novel means and methods for treating diseases of the central nervous system, metabolic and cardiac diseases and aging
09/26/2013WO2013139822A1 Novel bisoxime microbiocides
09/26/2013WO2013139799A1 Isoindolo[2,1-a]quinazoline derivatives for stabilization of organic materials
09/26/2013WO2013139730A1 Chemical compounds
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 1080